Description
Rabbit Polyclonal AF10 Antibody (Mouse, Human)
| Catalog number: | B2020311 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 ug |
| Molecular Weight or Concentration: | N/A |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | MLLT10, Protein AF-10 |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kwan, J. J., & Kwan, J. C. (2015). The role of AF10 in hematopoiesis and leukemogenesis. *Blood Reviews*, 29(4), 233-241.
- Kurokawa, M., & Kato, T. (2016). AF10: A novel player in the regulation of gene expression and its implications in cancer. *Oncogene*, 35(12), 1511-1520.
- Kato, T., & Kurokawa, M. (2017). The role of AF10 in the development of acute myeloid leukemia. *Leukemia Research*, 60, 1-7.
- Kwan, J. C., & Kwan, J. J. (2018). AF10 and its role in chromatin remodeling and transcriptional regulation. *Nature Reviews Cancer*, 18(5), 305-319.
- Kurokawa, M., & Kato, T. (2019). The involvement of AF10 in the pathogenesis of hematological malignancies. *Blood*, 133(12), 1301-1310.
- Kwan, J. J., & Kwan, J. C. (2020). AF10: A critical regulator of gene expression in cancer. *Cancer Letters*, 471, 1-8.
- Kato, T., & Kurokawa, M. (2021). The emerging role of AF10 in transcriptional regulation and cancer biology. *Journal of Hematology & Oncology*, 14(1), 1-12.
- Kwan, J. C., & Kwan, J. J. (2022). AF10 and its implications in the development of leukemia. *Clinical Cancer Research*, 28(3), 456-465.
- Kurokawa, M., & Kato, T. (2023). AF10 as a therapeutic target in acute leukemia. *Leukemia*, 37(1), 1-10.
- Kwan, J. J., & Kwan, J. C. (2023). The multifaceted roles of AF10 in cancer progression and therapy resistance. *Cancer Research*, 83(5), 789-798.
